1,394
Views
2
CrossRef citations to date
0
Altmetric
Article

A post hoc analysis of Dupuytren contracture treated with collagenase Clostridium histolyticum across disease stages

, , , & ORCID Icon
Pages 301-306 | Received 07 Feb 2018, Accepted 31 May 2018, Published online: 24 Jul 2018

References

  • Gudmundsson KG, Arngrı́msson R, Sigfússon N. Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik Study. J Clin Epidemiol. 2000;153:291–296.
  • Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital–a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord. 2007;8:60. PubMed PMID: 17610744; PubMed Central PMCID: PMCPMC1950875.
  • Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg Br. 1999;24:456–459.
  • Larsen S, Krogsgaard DG, Aagaard Larsen L, et al. Genetic and environmental influences in Dupuytren's disease: a study of 30,330 Danish twin pairs. J Hand Surg Eur Vol. 2015;40:171–176.
  • Eckerdal D, Nivestam A, Dahlin LB. Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes. BMC Musculoskelet Disord. 2014;15:117.
  • Huisstede BM, Hoogvliet P, Coert JH, et al. Dupuytren disease: European hand surgeons, hand therapists. And Physical Medicine and Rehabilitation Physicians Agree on a Multidisciplinary Treatment Guideline: results from the HANDGUIDE Study. Plast Reconstr Surg 2013;32:964e–976e.
  • Dias J, Bainbridge C, Leclercq C, et al. Surgical management of Dupuytren's contracture in Europe: regional analysis of a surgeon survey and patient chart review. Int J Clin Pract. 2013;67:271–281.
  • Denkler K. Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature. Eplasty 2010;10:e15.
  • Crean SM, Gerber RA, Le Graverand MP, et al. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies. J Hand Surg Eur Vol. 2011;36:396–407.
  • Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg Am. 2012;37:651–656.
  • McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren disease: long-term follow-up of a randomized controlled trial. J Hand Surg Am. 2014;39:1942–1947.
  • van Rijssen AL, Werker PM. Percutaneous needle fasciotomy for recurrent Dupuytren disease. J Hand Surg Am. 2012;37:1820–1823.
  • Gaston RG, Larsen SE, Pess GM, et al. The efficacy and safety of concurrent collagenase Clostridium Histolyticum injections for 2 dupuytren contractures in the same hand: a prospective, multicenter study. J Hand Surg Am. 2015;40:1963–1971.
  • Scherman P, Jenmalm P, Dahlin LB. One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: a two-centre prospective randomized clinical trial. J Hand Surg Eur Vol. 2016;41:577–582.
  • Werker PM, Pess GM, van Rijssen AL, et al. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am. 2012;37:2095–2105.
  • van Rijssen AL, Gerbrandy FS, Ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31:717–725.
  • Tubiana R, LC, Hurst LC, Badalamente MA, M, E. Dupuytren’s disease. Martin Dunitz, London. 2000;ISBN 1-85317-475-0.
  • Bainbridge C, Dahlin LB, Szczypa PP, et al. Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts. Eur Orthop Traumatol. 2012;3:31–41.
  • Sanjuan-Cervero R, Carrera-Hueso FJ, Vazquez-Ferreiro P, et al. Efficacy and adverse effects of collagenase use in the treatment of Dupuytren’s disease: a meta-analysis. Bone Joint J. 2018;100-B:73–80.
  • Strömberg J, Ibsen-Sörensen A, Fridén J. Comparison of treatment outcome after collagenase and needle fasciotomy for dupuytren contracture: a randomized, single-blinded, clinical trial with a 1-year follow-up. J Hand Surg Am. 2016;41:873–880.
  • Zhou C, Hovius SER, Pieters AJ, et al. Comparative effectiveness of needle aponeurotomy and collagenase injection for dupuytren's contracture: a multicenter study. Plast Reconstr Surg Glob Open. 2017;5:e1425.
  • Gilpin D, Coleman S, Hall S, et al. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease. J Hand Surg Am. 2010;35:2027–2038.
  • Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361:968–979.
  • van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129:469–477.
  • Skov ST, Bisgaard T, Sondergaard P, et al. Injectable collagenase versus percutaneous needle fasciotomy for dupuytren contracture in proximal interphalangeal joints: a randomized controlled trial. J Hand Surg Am. 2017;42:321–328.
  • Degreef I, De Smet L. Risk factors in Dupuytren’s diathesis: is recurrence after surgery predictable? Acta Orthop Belg. 2011;77:27–32.
  • Atroshi I, Nordenskjold J, Lauritzson A, et al. Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome. Acta Orthop. 2015;86:310–315.
  • Riley KN, Herman IM. Collagenase promotes the cellular responses to injury and wound healing in vivo. J Burns Wounds 2005;74:e8.